836 related articles for article (PubMed ID: 15956019)
1. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
2. Syringetin, a flavonoid derivative in grape and wine, induces human osteoblast differentiation through bone morphogenetic protein-2/extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Liang HL; Hung CH; Kuo PL
Mol Nutr Food Res; 2009 Nov; 53(11):1452-61. PubMed ID: 19784998
[TBL] [Abstract][Full Text] [Related]
3. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2.
Lou J; Tu Y; Li S; Manske PR
Biochem Biophys Res Commun; 2000 Feb; 268(3):757-62. PubMed ID: 10679278
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
9. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.
Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL
Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway.
Luo XH; Guo LJ; Yuan LQ; Xie H; Zhou HD; Wu XP; Liao EY
Exp Cell Res; 2005 Sep; 309(1):99-109. PubMed ID: 15963981
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway.
Che J; Chan ES; Cronstein BN
Mol Pharmacol; 2007 Dec; 72(6):1626-36. PubMed ID: 17872970
[TBL] [Abstract][Full Text] [Related]
12. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
13. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway.
Chen PY; Sun JS; Tsuang YH; Chen MH; Weng PW; Lin FH
Nutr Res; 2010 Mar; 30(3):191-9. PubMed ID: 20417880
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
16. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2.
Yuasa T; Kataoka H; Kinto N; Iwamoto M; Enomoto-Iwamoto M; Iemura S; Ueno N; Shibata Y; Kurosawa H; Yamaguchi A
J Cell Physiol; 2002 Nov; 193(2):225-32. PubMed ID: 12385000
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype.
Zhao M; Xiao G; Berry JE; Franceschi RT; Reddi A; Somerman MJ
J Bone Miner Res; 2002 Aug; 17(8):1441-51. PubMed ID: 12162498
[TBL] [Abstract][Full Text] [Related]
20. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
